Studies on the safety and efficacy of focal transurethral resection of prostate cancer as a focal therapy for localized prostate cancer

Studies on the safety and efficacy of focal transurethral resection of prostate cancer as a focal therapy for localized prostate cancer - Focal transurethral resection of prostate cancer (TUR-PCa) for localized prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016924

Enrollment

Registered

2015-03-26

Start date

2015-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

localized prostate cancer

Interventions

Focal transurethral resection of prostate cancer (TUR-PCa)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with localized prostate cancer (T1,2N0M0) Patients with BPH Patients who agreed to be enrolled in the study

Exclusion criteria

Exclusion criteria: Patients who have cancer foci near bilateral nerurovascular bundle Patients who are considered not to tolerate TURP Patients who are considered inappropriate by the doctors

Design outcomes

Primary

Measure	Time frame
biochemical non-recurrence rate	—

Countries

Japan

Contacts

Public ContactTakeshi Matsuura

Matsubara Tokushukai Hospital Urology

tmatsuura-jua@umin.ac.jp072-334-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026